This looks to be a huge step forward for epilepsy and GW Pharma - an exciting prospect for all those affected. 

With GW Pharma the only UK based Pharmaceutical Company, researching the cannabis plant - could other pharma companies out there be missing a trick? Is there much potential in cannabis other than treatment related to Epilepsy?